BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 34248970)

  • 21. PTX3 Intercepts Vascular Inflammation in Systemic Immune-Mediated Diseases.
    Ramirez GA; Rovere-Querini P; Blasi M; Sartorelli S; Di Chio MC; Baldini M; De Lorenzo R; Bozzolo EP; Leone R; Mantovani A; Manfredi AA; Tombetti E
    Front Immunol; 2019; 10():1135. PubMed ID: 31191526
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fcgamma receptor expression levels on monocytes are elevated in rheumatoid arthritis patients with high erythrocyte sedimentation rate who do not use anti-rheumatic drugs.
    Wijngaarden S; van Roon JA; Bijlsma JW; van de Winkel JG; Lafeber FP
    Rheumatology (Oxford); 2003 May; 42(5):681-8. PubMed ID: 12709546
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Leptin consumption in the inflamed joints of patients with rheumatoid arthritis.
    Bokarewa M; Bokarew D; Hultgren O; Tarkowski A
    Ann Rheum Dis; 2003 Oct; 62(10):952-6. PubMed ID: 12972473
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Infiltrations of plasma cells in synovium are highly associated with synovial fluid levels of APRIL in inflamed peripheral joints of rheumatoid arthritis.
    Dong W; Li X; Liu H; Zhu P
    Rheumatol Int; 2009 May; 29(7):801-6. PubMed ID: 19037609
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Geranylgeranyl-pyrophosphate regulates secretion of pentraxin 3 and monocyte chemoattractant protein-1 from rheumatoid fibroblast-like synoviocytes in distinct manners.
    Yokota K; Miyoshi F; Sato K; Asanuma Y; Akiyama Y; Mimura T
    Clin Exp Rheumatol; 2011; 29(1):43-9. PubMed ID: 21345291
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum pentraxin 3 levels are negatively associated with carotid intima media thickness in non-obese rheumatoid arthritis patients.
    Kahlow BS; Petisco R; Skare TL; Goeldner I; Nisihara RM; Messias-Reason IJ
    Int J Cardiol; 2016 Oct; 221():298-301. PubMed ID: 27404695
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Soluble OX40L is associated with presence of autoantibodies in early rheumatoid arthritis.
    Laustsen JK; Rasmussen TK; Stengaard-Pedersen K; Hørslev-Petersen K; Hetland ML; Østergaard M; Junker P; Hvid M; Deleuran B
    Arthritis Res Ther; 2014 Oct; 16(5):474. PubMed ID: 25359291
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Autoantibodies to posttranslationally modified type II collagen as potential biomarkers for rheumatoid arthritis.
    Strollo R; Ponchel F; Malmström V; Rizzo P; Bombardieri M; Wenham CY; Landy R; Perret D; Watt F; Corrigall VM; Winyard PG; Pozzilli P; Conaghan PG; Panayi GS; Klareskog L; Emery P; Nissim A
    Arthritis Rheum; 2013 Jul; 65(7):1702-12. PubMed ID: 23575908
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased perivascular synovial membrane expression of myeloid-related proteins in psoriatic arthritis.
    Kane D; Roth J; Frosch M; Vogl T; Bresnihan B; FitzGerald O
    Arthritis Rheum; 2003 Jun; 48(6):1676-85. PubMed ID: 12794836
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Selective Increment of Synovial Soluble TYRO3 Correlates with Disease Severity and Joint Inflammation in Patients with Rheumatoid Arthritis.
    Vullings J; Vago JP; Waterborg CEJ; Thurlings RM; Koenders MI; van Lent PLEM; van der Kraan PM; Amaral FA; van de Loo FAJ
    J Immunol Res; 2020; 2020():9690832. PubMed ID: 32964059
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synovial Immunophenotype and Anti-Citrullinated Peptide Antibodies in Rheumatoid Arthritis Patients: Relationship to Treatment Response and Radiologic Prognosis.
    Orr C; Najm A; Biniecka M; McGarry T; Ng CT; Young F; Fearon U; Veale DJ
    Arthritis Rheumatol; 2017 Nov; 69(11):2114-2123. PubMed ID: 28732135
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interleukin-29 modulates proinflammatory cytokine production in synovial inflammation of rheumatoid arthritis.
    Wang F; Xu L; Feng X; Guo D; Tan W; Zhang M
    Arthritis Res Ther; 2012 Oct; 14(5):R228. PubMed ID: 23078630
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased levels of thymosin β4 in synovial fluid of patients with rheumatoid arthritis: association of thymosin β4 with other factors that are involved in inflammation and bone erosion in joints.
    Choi HM; Lee YA; Yang HI; Yoo MC; Kim KS
    Int J Rheum Dis; 2011 Oct; 14(4):320-4. PubMed ID: 22004227
    [TBL] [Abstract][Full Text] [Related]  

  • 34. GM-CSF Expression and Macrophage Polarization in Joints of Undifferentiated Arthritis Patients Evolving to Rheumatoid Arthritis or Psoriatic Arthritis.
    Fuentelsaz-Romero S; Cuervo A; Estrada-Capetillo L; Celis R; García-Campos R; Ramírez J; Sastre S; Samaniego R; Puig-Kröger A; Cañete JD
    Front Immunol; 2020; 11():613975. PubMed ID: 33679701
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Source of Circulating Pentraxin 3 in Septic Shock Patients.
    Albert Vega C; Mommert M; Boccard M; Rimmelé T; Venet F; Pachot A; Leray V; Monneret G; Delwarde B; Brengel-Pesce K; Mallet F; Trouillet-Assant S
    Front Immunol; 2018; 9():3048. PubMed ID: 30687307
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Distribution of Podoplanin in Synovial Tissues in Rheumatoid Arthritis Patients Using Biologic or Conventional Disease-Modifying Anti-Rheumatic Drugs.
    Takakubo Y; Oki H; Naganuma Y; Saski K; Sasaki A; Tamaki Y; Suran Y; Konta T; Takagi M
    Curr Rheumatol Rev; 2017; 13(1):72-78. PubMed ID: 27030253
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Down-regulation of leucocyte immunoglobulin-like receptor expression in the synovium of rheumatoid arthritis patients after treatment with disease-modifying anti-rheumatic drugs.
    Huynh OA; Hampartzoumian T; Arm JP; Hunt J; Borges L; Ahern M; Smith M; Geczy CL; McNeil HP; Tedla N
    Rheumatology (Oxford); 2007 May; 46(5):742-51. PubMed ID: 17202177
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PTX3 in small-vessel vasculitides: an independent indicator of disease activity produced at sites of inflammation.
    Fazzini F; Peri G; Doni A; Dell'Antonio G; Dal Cin E; Bozzolo E; D'Auria F; Praderio L; Ciboddo G; Sabbadini MG; Manfredi AA; Mantovani A; Querini PR
    Arthritis Rheum; 2001 Dec; 44(12):2841-50. PubMed ID: 11762945
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Involvement of breast cancer resistance protein expression on rheumatoid arthritis synovial tissue macrophages in resistance to methotrexate and leflunomide.
    van der Heijden JW; Oerlemans R; Tak PP; Assaraf YG; Kraan MC; Scheffer GL; van der Laken CJ; Lems WF; Scheper RJ; Dijkmans BA; Jansen G
    Arthritis Rheum; 2009 Mar; 60(3):669-77. PubMed ID: 19248091
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pentraxin 3 Is Closely Associated With Tubulointerstitial Injury in Lupus Nephritis: A Large Multicenter Cross-Sectional Study.
    Pang Y; Tan Y; Li Y; Zhang J; Guo Y; Guo Z; Zhang C; Yu F; Zhao MH
    Medicine (Baltimore); 2016 Jan; 95(3):e2520. PubMed ID: 26817892
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.